在小鼠中,阿巴洛帕拉提德通过增加骨质形成来增加骨质量,而不考虑先前对阿伦德罗纳特进行治疗
Akito Makino1, Tomoka Hasegawa2, Tomomaya Yamamoto2
1Teijin Institute for Bio-medical Research, Teijin Pharma Limited, Tokyo, Japan.
Journal of oral biosciences
|February 19, 2026
概括
阿巴洛帕拉提德 (ABL) 有效地促进了小鼠的骨形成,无论之前的阿伦德罗纳酸 (ALN) 治疗如何. 这项研究表明,ABL可增强骨矿物质密度和骨质母细胞活性,即使在小鼠接受双酸盐预处理时也是如此.
科学领域:
- 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
- 骨质疏松症的研究研究.
背景情况:
- 像阿伦德罗纳特 (ALN) 这样的双酸盐是常见的骨质疏松症治疗方法.
- 阿巴洛帕拉提德 (ABL) 是一种用于治疗骨质疏松症的骨类合成药物.
- 双酸盐与较新的合成代谢剂之间的相互作用需要进行调查.
研究的目的:
- 在小鼠模型中研究双酸盐预处理对阿巴洛帕拉提德对骨合成效应的影响.
- 为了确定先前的阿伦德罗纳特给药是否会影响阿巴洛帕拉提德促进骨形成的疗效.
主要方法:
- 在21天的时间里,小鼠接受了不同剂量的阿伦德罗酸盐 (ALN) 的预治疗.
- 在ALN预治疗后,小鼠接受了阿巴洛帕拉提德 (ABL) 28天.
- 分析了大腿骨矿物质密度和骨组织学 (骨质细胞和骨质细胞标记物).
主要成果:
- 阿巴洛帕拉提德 (ABL) 增加了大腿骨矿物质密度,而不考虑阿伦德罗纳特 (ALN) 预处理.
- 组织学分析证实了骨质细胞标志物 (ALPase,PHOSPHO1) 与ABL的增加,独立于ALN.
- 阿巴洛帕拉提德对骨质细胞标记物 (TRAP) 的刺激在较高的阿伦德罗纳特剂量下降.
结论:
- 阿巴洛帕拉提德 (ABL) 在小鼠中表现出显著的骨类合成效应,独立于先前的双酸盐 (阿伦德罗酸盐) 暴露.
- 组合疗法表明,ABL有可能促进骨形成,即使在以前接受过双酸盐治疗的患者中也是如此.
- 需要进一步的研究来探索这种药物相互作用在骨质疏松症管理中的临床影响.
相关概念视频
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Hormones and Bone Tissue
3.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K


